Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Parametric and the Cox risk model in the analysis of factors affecting the time of diagnosis of retinopathy with patients type 2 diabetes

1 Department of Biostatistics, Faculty of Health, Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran

Special Issues: Innovations in Immunology

Background: The aim of this study was to compare the effectiveness of Cox model and Exponential parametric, Weibull, Log Normal and Log Logistic models in evaluating factors affecting retinopathy diagnostic time in patients with type 2 diabetes. Methods: In this prospective historical study, 400 patients with type 2 diabetes without retinopathy referred to the Ophthalmology Clinic of Yazd Diabetes Research Center in 2008 were followed up for diagnosis of retinopathy by January 2013. Significant variables in the univariate model were introduced into the Cox multivariate and parametric models to determine the effective factors on the time of retinopathy diagnosis. The criterion for comparing the performance of the models was the Akaike’s criterion. All calculations were performed using R software and a significant level of 0.05 was considered. Resuls: The mean and median time of retinopathy diagnosis was 52.46 and 58 months, respectively. 3% of patients in less than one year and 16% of patients in less than two years of retinopathy were diagnosed. Conclusion: According to Akaike’s criterion, Cox model has the best fit in determining the factors affecting the time of retinopathy diagnosis.
  Figure/Table
  Supplementary
  Article Metrics

Keywords diabetes; diabetic retinopathy; Cox model; parametric models; Akaike’s criteria

Citation: Fatemeh keshavarzi, Mohsen Askarishahi, Maryam Gholamniya Foumani, Hossein Falahzadeh. Parametric and the Cox risk model in the analysis of factors affecting the time of diagnosis of retinopathy with patients type 2 diabetes. AIMS Medical Science, 2019, 6(2): 170-178. doi: 10.3934/medsci.2019.2.170

References

  • 1. Kleinbaum D (2004) Survival Analysis a Self-Learning Text. New York: Springer.
  • 2. Salehi M, Vazirinasab H, Khoshgam M, et al. (2012) Application of the generalized additive model in determination of the retinopathy risk factors relation types for Tehran diabetic patients. Razi J Med Sci 97: 1–9.
  • 3. Gaafar M, Khattab A (2013) Prevalence and Predictors of Diabetic Retinopathy Among Elderly type II diabetics. Am Sci 9: 639–646.
  • 4. Kostev K, Rathmann W (2013) Diabetic retinopathy at diagnosis of type 2 diabetesin the UK: a database analysis. Diabetologia 56: 109–111.    
  • 5. DeFronzo RA (2018) Pathogenesis of type 2 diabetes mellitus. Diabetes Epidemiol Genet Pathog Diagn Prev Treat: 181–253.
  • 6. Mackenbach JD, den Braver NR, Beulens JWJ (2018) Spouses, social networks and other upstream determinants of type 2 diabetes mellitus. Diabetologia 61: 1517–1521.    
  • 7. Walker J, Colhoun H, Livingstone S, et al. (2018) Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): a population-based observational study. Diabetologia 61: 108–116.    
  • 8. Walker JJ, Livingstone SJ, Colhoun HM, et al. (2011) Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes. Diabetes Care 34: 1127.    
  • 9. Hjelmgren O, Strömberg U, Gellerman K, et al. (2019) Does retinopathy predict stroke recurrence in type 2 diabetes patients: A retrospective study? PloS One 14: e0210832.    
  • 10. Groeneveld Y, Tavenier D, Blom JW, et al. (2019) Incidence of sight‐threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review. Diabetic Med.
  • 11. Srinivasan R (2018) Diabetes mellitus: Can retinopathy be far behind? J Curr Res Sci Med 4: 78.
  • 12. Ngandu NH (1997) An empirical comparison of statistical tests for assessing the proportional Hazards Assumption of Cox's Model. Stat Med 16: 611–626.    
  • 13. Askarishahi M, Hajizadeh E, Afkhami-Ardekani M (2011) Factors affecting retinopathy in patients with type 2 diabetes by analyzing the current status data. Tehran Univ Med J 68: 674–680.
  • 14. Kohian H, Sohrabi MB, Zolfaghari P, et al. (2013) The Prevalence and Related Factors of Diabetic Retinopathy in Shahroud. Knowl Health J 7: 179–184.
  • 15. Manaviat M, AfkhamiArdekani M, Rashidi M (2006) Assessment four-year incidence of retinopathy and its risk factors in type II diabetes. J Shaeed Sdoughi Univ Med Sci Yazd 14: 11–19.
  • 16. Zhang X, Saaddine J, Chou C, et al. (2010) Prevalence of Diabetic Retinopathy in the United States, 2005–2008. JAm Med Assoc 304: 649–656.    
  • 17. Rani PK, Raman R, Rachepalli SR, et al. (2010) Anemia and Diabetic Retinopathy in Type 2 Diabetes Mellitus. J Assoc Physicians India 58: 91–94.
  • 18. Francisco J, Patricia P, Martha G, et al. (2012) Anemia as a factor related to the progression of proliferative diabetic retinopathy after photocoagulation. J Diabetes Complications 26: 454–457.    
  • 19. Diep TM, Tsui I (2013) Risk factors associated with diabetic macular edema. Diabetes Res Clin Pract 100: 298–305.    
  • 20. Aghadoust D, Sadr F (2005) Prevalence and risk factors of diabetic retinopathy in diabetic patients referred to Kashan Diabetes center in 1381-1382. Q J Fyz 33.
  • 21. Shafiepour L, Ahmadzade A, Shafiepour V, et al. (2006) Prevalence of diabetic retinopathy and associated risk factors among Patients referred to Hospital Imam Khomeini Surrey city. J Mazandaran Univ Med Sci 16: 125–130.
  • 22. He BB, Wei L, Gu YJ, et al. (2012) Factors Associated with Diabetic Retinopathy in Chinese Patients with Type2 Diabetes Mellitus. Int J Endocrinol.
  • 23. Bueso SE, Vigo SJ, Pereze F, et al. (2005) Prevalence of diabetic retinopathy in the regional community of Extremadura 1997-2001. Arch Soc Esp Oftalmol 80: 187–189.
  • 24. Rajaeefard A, Dehkordi B, Tabatabaee H, et al. (2009) Applying parametric models for survival analysis of gastric cancer. Arch SID 13: 83–88.
  • 25. Rover G, Sabharwal A (2012) A Parametric Approach to Estimate Survival time of diabetic nephropaty with left truncated and right censored data. IntJ stat Probab 1: 128–137.
  • 26. Orbe J, Ferreira E, Nunez-Anton V (2002) Comparing proportional hazards and accelerated failure time models for survival analysis. Stat Med 21: 493–510.
  • 27. Giolo SR, Krieger JE, Mansur AJ, et al. (2012) Survival Analysis of Patients with Heart Failure Implications of Time-Varying Regression Effects in Modeling Mortality. PloS One 7: 1–8.

 

Reader Comments

your name: *   your email: *  

© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved